Guggenheim Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$1.66M Buy
2022
Q1
$330K Buy
2021
Q4
$563K Buy
2021
Q3
$717K Buy
2021
Q2
$724K Buy
2021
Q1
$763K Buy
2020
Q4
$514K Buy